tiprankstipranks
Advertisement
Advertisement
Corcept Rockets 48% after FDA Lifyorli Approval — What Does This Mean for CORT Stock?
PremiumMarket NewsCorcept Rockets 48% after FDA Lifyorli Approval — What Does This Mean for CORT Stock?
22d ago
Enphase, AST SpaceMobile, AppLovin, ConocoPhillips, Teva Shock
Premium
Weekend Updates
Enphase, AST SpaceMobile, AppLovin, ConocoPhillips, Teva Shock
26d ago
Teva price target raised to $41 from $40 at Piper Sandler
Premium
The Fly
Teva price target raised to $41 from $40 at Piper Sandler
1M ago
Corcept Therapeutics price target lowered to $67 from $105 at H.C. Wainwright
PremiumThe FlyCorcept Therapeutics price target lowered to $67 from $105 at H.C. Wainwright
2M ago
Corcept ‘disappointed’ in court ruling over Teva patent dispute
Premium
The Fly
Corcept ‘disappointed’ in court ruling over Teva patent dispute
2M ago
Midday Fly By: Walmart reports Q4 beat, eBay to acquire Depop from Etsy
Premium
The Fly
Midday Fly By: Walmart reports Q4 beat, eBay to acquire Depop from Etsy
2M ago
Teva and Sanofi’s duvakitug Phase 2b data shows efficacy in colitis and Crohn’s
PremiumThe FlyTeva and Sanofi’s duvakitug Phase 2b data shows efficacy in colitis and Crohn’s
2M ago
Teva price target raised to $45 from $36 at Goldman Sachs
Premium
The Fly
Teva price target raised to $45 from $36 at Goldman Sachs
2M ago
Teva’s Sustainability Disclosures Face Rising Legal and Investor Risk Amid Global Compliance Demands
Premium
Company Announcements
Teva’s Sustainability Disclosures Face Rising Legal and Investor Risk Amid Global Compliance Demands
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100